MEDX Holdings — Horizon Kinetics Medical ETF
All 33 reported holdings of Horizon Kinetics Medical ETF (MEDX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 15.59% | $2.83M |
| US Bank Mmda - Usbgfs 7 | 10.03% | $1.82M |
| AbbVie Inc | 8.43% | $1.53M |
| Novartis AG | 7.40% | $1.34M |
| Johnson & Johnson | 5.93% | $1.08M |
| AstraZeneca PLC | 5.71% | $1.04M |
| Bristol-Myers Squibb Co | 5.13% | $930.86K |
| Ionis Pharmaceuticals Inc | 4.73% | $858.13K |
| Amgen Inc | 4.19% | $760.35K |
| Alnylam Pharmaceuticals Inc | 4.14% | $751.74K |
| Alkermes PLC | 4.11% | $746.06K |
| Merck & Co Inc | 4.08% | $740.26K |
| Pfizer Inc | 3.67% | $666.51K |
| Gsk PLC | 3.14% | $569.51K |
| Biogen Inc | 2.88% | $523.77K |
| Regeneron Pharmaceuticals Inc | 2.81% | $509.94K |
| CRISPR Therapeutics AG | 2.53% | $460.05K |
| Beam Therapeutics Inc | 1.15% | $209.49K |
| Intellia Therapeutics Inc | 0.93% | $169.07K |
| Vanda Pharmaceuticals Inc | 0.90% | $164.02K |
| Sandoz Group AG | 0.76% | $137.63K |
| Galectin Therapeutics Inc | 0.76% | $137.34K |
| Haleon PLC | 0.71% | $129.13K |
| Replimune Group Inc | 0.56% | $100.89K |
| Editas Medicine Inc | 0.39% | $71.65K |
| GE HealthCare Technologies Inc | 0.34% | $62.64K |
| Bicycle Therapeutics PLC | 0.34% | $61.19K |
| Viatris Inc | 0.24% | $44.20K |
| Allogene Therapeutics Inc | 0.24% | $42.90K |
| Lantern Pharma Inc | 0.20% | $36.13K |
| Pacific Biosciences of Califor | 0.08% | $13.93K |
| Decoy Therapeutics Inc | 0.00% | $136 |
| Pathos AI Inc | 0.00% | $0 |
MEDX overview: performance, fees, allocation and SEC filings